Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Health Reform To Trim Hospital Involvement In Drug Sales

This article was originally published in PharmAsia News

Executive Summary

China's massive health care reform plan is set for release in March, according to Health Minister Chen Zhu. The country has faced soaring medical costs in recent years, leading to poverty in some areas. Reforms were made in four aspects of China's health system, including drug supplies. In that area, the plan is to reduce hospital involvement in drug sales to keep doctors from acting in the best interests of big pharmaceutical companies, Chen said. The other three reform areas are public health care, medical treatment and medical insurance. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066675

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel